Brian Foard has been named Head of the Sanofi's Specialty Care Global Business Unit (GBU). With this appointment, which is effective immediately, Brian becomes a member of Sanofi's Executive Committee. Brian has been interim Head of the GBU since September 2023 while also serving as Head of Specialty Care North America and U.S. Country Lead.

Brian, who has more than 20 years of specialty biopharma experience, has been at the helm of the successful launch of Dupixent(R) in more than 50 countries across multiple indications and age groups prior to his current role. Brian joined Sanofi in March 2017 as the Global Head of Dermatology and Respiratory, and held roles of increasing responsibility, including as Head of Global Immunology for Sanofi. He began his career with Galderma and spent more than 10 years in the U.S. before relocating to Paris to lead global marketing and launch readiness.

During his time at Galderma, Brian also served in roles including General Manager for Australia & New Zealand and Vice President & General Manager of the global prescription business unit. Brian received a degree in business from East Carolina University and has completed an executive education course at Wharton. He will be based in Cambridge, Massachusetts.